000 01444 a2200433 4500
005 20250517055053.0
264 0 _c20171222
008 201712s 0 0 eng d
022 _a1464-3804
024 7 _a10.1093/mutage/gev070
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTweats, David J
245 0 0 _aGenotoxicity of flubendazole and its metabolites in vitro and the impact of a new formulation on in vivo aneugenicity.
_h[electronic resource]
260 _bMutagenesis
_c05 2016
300 _a309-21 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActivation, Metabolic
650 0 4 _aAneugens
_xmetabolism
650 0 4 _aAnimals
650 0 4 _aAntinematodal Agents
_xmetabolism
650 0 4 _aCells, Cultured
650 0 4 _aChromosome Aberrations
650 0 4 _aChromosomes, Human
_xdrug effects
650 0 4 _aDNA
_xdrug effects
650 0 4 _aDNA Damage
650 0 4 _aHumans
650 0 4 _aLymphocytes
_xdrug effects
650 0 4 _aMale
650 0 4 _aMebendazole
_xanalogs & derivatives
650 0 4 _aMicronucleus Tests
650 0 4 _aMutagens
_xmetabolism
650 0 4 _aRats
700 1 _aJohnson, George E
700 1 _aScandale, Ivan
700 1 _aWhitwell, James
700 1 _aEvans, Dean B
773 0 _tMutagenesis
_gvol. 31
_gno. 3
_gp. 309-21
856 4 0 _uhttps://doi.org/10.1093/mutage/gev070
_zAvailable from publisher's website
999 _c25331804
_d25331804